Latest News about RLMD
Recent news which mentions RLMD
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
October 14, 2022
From Benzinga
From Benzinga
Dow Surges 950 Points; S&P 500 Rises 3%
October 13, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 13, 2022
From Benzinga
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
October 13, 2022
From InvestorPlace
Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
October 13, 2022
From Benzinga
Gold Down 1.5%; Domino's Pizza Shares Spike Higher
October 13, 2022
From Benzinga
Why Are Tech Stocks Down Today?
October 13, 2022
Tags
Market News
NASDAQ:META,NASDAQ:GOOGL,NASDAQ:GOOG,NASDAQ:AMZN,NASDAQ:AAPL,NASDAQ:DWAC,NASDAQ:RLMD
Today's Market
From InvestorPlace
From Benzinga
Why Is Relmada (RLMD) Stock Down 78% Today?
October 13, 2022
From InvestorPlace
Relmada Stock Tumbles To 52-Week Low On Failed Depression Trial
October 13, 2022
Tickers
RLMD
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 13, 2022
From Benzinga
Why Relmada Therapeutics Shares Are Trading Lower By 84%; Here Are 23 Stocks Moving Premarket
October 13, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 20, 2022
From Benzinga
The Bull Market Is Still Alive
August 29, 2022
From InvestorPlace
The Bull Market Is Still Alive
August 29, 2022
From InvestorPlace
From InvestorPlace
Earnings Scheduled For August 11, 2022
August 11, 2022
From Benzinga
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
August 09, 2022
From Benzinga
10 Biggest Price Target Changes For Monday
May 09, 2022
From Benzinga
From Benzinga
Earnings Scheduled For March 23, 2022
March 23, 2022
From Benzinga
Relmada Aces REL-1017 Vs Ketamine Study For Abuse Potential
February 23, 2022
Tickers
RLMD
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
From Benzinga
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
December 09, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.